Avila EK, Chamberlain M, Schiff D, et al. Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials. Neuro Oncol. 2017;19(1):12-21.
Brown PD, Butts AM, Parsons MW, Cerhan JH. Neurocognitive effects. In DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 11th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2019: 2155-2173.
Costa J, Haddad FG, Costa G, Harb A, Eid R, Kourie HR, Helou JE. Seizures in cancer patients: A vast spectrum of etiologies. Future Neurology. 2019;14(4):doi:10.2217/fnl-2019-0015.
Yust-Katz S, Khagi S, Gilbert MR. Neurologic complications. In Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, PA: Elsevier; 2020:688-.706